Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
Clinical trial NCT03609593 · COMPLETED
Trial details
- NCT number
- NCT03609593
- Sponsor
- Nicole Lamanna
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2026-01-27
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.